Adverum Biotechnologies Reports First Quarter 2022 Financial Results

12.05.2022 - REDWOOD CITY, Calif., May 12, 2022 (GLOBE NEWSWIRE) - Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today reported financial results for the first ...

Related Keywords

,Sooj Hong ,Richard Beckman ,Laurence Watts ,Cone Monochromacy ,Anand Reddi ,Rabia Gurses Ozden ,Adverum Biotechnologies Inc ,American Society Of Gene Cell Therapy ,Drug Administration ,Exchange Commission ,Affairs Engagement ,Gilmartin Group ,Corporate Communications ,Association For Research ,Orphan Drug Designation ,Star Seyedkazemi ,Gurses Ozden ,Investigational New Drug ,American Society ,Cell Therapy ,Three Months Ended March ,Private Securities Litigation Reform ,Annual Report ,Corporate Strategy ,External Affairs ,